Famotidine/Omeprazole

法莫替丁/奥美拉唑

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFamotidine/Omeprazole
Drug Alias NameOmeprazole and Famotidine奥美拉唑法莫替丁法莫替丁奥美拉唑Omeprazole/Famotidine奥美拉唑/法莫替丁 +[7] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H2 receptor antagonistsProton pump inhibitors
TargetsProton pumpHistamine H2 receptor
Therapy Area/IndicationsGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes OmeprazoleFamotidine
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrexo Ab (Pulb)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrexo Ab (Pulb)
Active IndicationsN/A
Inactive IndicationsGastroesophageal Reflux

Other Information

ATC CodeN/A
Related LinksN/A